[BrainConnexion] - Neurodevice Phase II Trial
Last updated on July 2021Recruitment
- Recruitment Status
- Active, not recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Amyotrophic Lateral Sclerosis
- Locked-in Syndrome
- Motor Neuron Disease
- Muscular Dystrophies
- Spinal Cord Injuries
- Tetraplegia
- Tetraplegia/Tetraparesis
- Type
- Interventional
- Phase
- Not Applicable
- Design
- Allocation: N/AIntervention Model: Single Group AssignmentMasking: None (Open Label)Primary Purpose: Other
Participation Requirements
- Age
- Between 21 years and 70 years
- Gender
- Both males and females
Description
The goal of this study is to develop a miniaturized wireless implantable neurodevice microsystem that records and transmits signals from the motor cortex of tetraplegic patients, bypassing the damaged nervous tissue, to control an external assistive device that restores some form of independence to ...
The goal of this study is to develop a miniaturized wireless implantable neurodevice microsystem that records and transmits signals from the motor cortex of tetraplegic patients, bypassing the damaged nervous tissue, to control an external assistive device that restores some form of independence to patients in terms of communication or mobility.
Tracking Information
- NCT #
- NCT03811301
- Collaborators
- Institute of Microelectronics
- Institute of Molecular and Cell Biology
- Institute for Infocomm Research
- Nanyang Technological University
- Investigators
- Not Provided
Get Well Soon